Key result
MMP9 deletion or inhibition protects mice against sepsis and myocardial dysfunction by reducing inflammatory cytokines.
Why the study?
Metalloproteinase9 is an important inflammatory mediator, but its contribution to sepsis-induced myocardial dysfunction remains unclear.
Does MMP9 inhibition or deletion prevent sepsis-induced myocardial dysfunction in mouse models?
Does MMP9 inhibition or deletion prevent sepsis-induced myocardial dysfunction in mouse models?
MMP9 deficiency or pharmacological inhibition protects against sepsis-induced myocardial dysfunction by suppressing dendritic cell-mediated inflammation and cardiomyocyte death.
Metalloproteinase9 is an important inflammatory mediator, but its contribution to sepsis-induced myocardial dysfunction (SIMD) remains unclear. In this study, we found that MMP9 deletion in mice evoked resistance to LPS-triggered septic cardiac dysfunction and lethality, accompanied by heavily reduced serum level of inflammatory factors and the myocardial damage markers. Similar results were acquired when an MMP9 inhibitor was used to treat LPS-induced sepsis, indicating that MMP9 promoted the progression of SIMD. It is well-known that DCs can induce inflammatory response to promote septic tissue damage. Notably, MMP9-/- BMDCs were significantly more effective in reducing sepsis-induced myocardial dysfunction compared to WT BMDCs. Mechanistically, MMP9 deficiency in BMDCs mainly curtailed the release of IL-6, IL-1β, IL-17 A, and nitric oxide via the JNK/AP1 pathway, thus safeguarding cardiomyocytes from death. Collectively, this study contributed new insights into the role of MMP9 in DCs within the context of SIMD.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2026) studied Sepsis-induced myocardial dysfunction (SIMD). MMP9 deletion or MMP9 inhibitor (MMP-9-IN-1) vs. Wild type (WT) mice or PBS was evaluated on Survival and cardiac dysfunction. MMP9 deletion or pharmacological inhibition protected mice against LPS-induced sepsis and myocardial dysfunction by reducing dendritic cell-mediated inflammatory cytokine release.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: